Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer
CAP, ASCO reduce confusion by reaffirming HER2 testing guidelines
The organizations reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.
June 8, 2023
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
The device has conducted more than 180 thousand assessments in pharmacies and primary care clinics in Europe; DeepX is poised to enter the U.S. market.
June 6, 2023
Dante Genomics introduces rare disease health package that leverages telemedicine, sequencing
The package includes telemedicine consultations with specialists who may not be available where a patient is located.
June 6, 2023
Low rates of genetic testing ‘a missed opportunity’ to reduce cancer burden
The probability of a patient undergoing genetic testing increased over the course of the study, although male breast was the only indication that had a more than 50% likelihood of being tested at any time.
June 5, 2023
Grail, University of Oxford announce data from large-scale evaluation of multicancer early detection test
Investigators at the ASCO annual meeting described the performance of Grail’s multicancer early detection methylation-based platform, Galleri, in a symptomatic population of more than 6,000 patients.
June 5, 2023
Invivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detection
Under the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.
June 2, 2023
Labcorp launches liquid biopsy test for oncology
The test, called Labcorp Plasma Focus, enables treating oncologists to evaluate circulating cell-free DNA released by tumor cells.
June 1, 2023
Nucleai, Adlai Nortye collaborate on biomarkers for clinical trials
The partnership will combine Nucleai's expertise in extracting and analyzing the quantitative spatial features of pathology images and Adlai Nortye's expertise in drug development and immunotherapy.
May 31, 2023
Single-cell RNA sequencing data reveals T cells linked to cancer immunotherapy resistance
Scientists at the University of Texas MD Anderson Cancer Center have provided a new explanation for why checkpoint inhibitors are ineffective in some patients.
May 30, 2023
Bacteria vary between early- and late-onset colorectal cancer tumors: Study
Bacteria types vary widely between early- versus late-onset colorectal cancer tumors, providing clues to the disease’s increase in younger people, according to a study.
May 30, 2023
At ASCO meeting, Veracyte highlights prostate cancer study data using genomics database
The Decipher GRID database, which is used by Veracyte and its partners in urologic cancer research, comprises more than 100,000 whole-transcriptome profiles from patients with urologic cancers.
May 30, 2023
Lunit, Japan national cancer center collaborate on AI-based pathology for oncology
In collaborative studies with the national cancer center, researchers are evaluating the potential of the Lunit Scope artificial intelligence biomarker platform to predict clinical outcomes for rectal cancer.
May 30, 2023
Page 1 of 86
Next Page
